Suggestions

Reports - Page 2

Chronic Refractory Cough Market
··

Chronic Refractory Cough Market Hits $8.5B in 2024!

The chronic refractory cough (CRC) market is projected to witness substantial growth through 2034, driven by an expanding diagnosed patient population, increasing recognition of chronic cough as a distinct clinical condition, and the shortcomings of currently used off-label therapies. Chronic Refractory Cough
21 January 2026
Complement 3 Glomerulopathy Market
·

Complement 3 Glomerulopathy (C3G) Market Forecast 2034

The Complement 3 Glomerulopathy (C3G) market is poised for significant growth, driven by a deeper understanding of complement pathway dysregulation, improved diagnostic capabilities, and the introduction of novel targeted therapies such as Factor B inhibitors, C3 inhibitors, MASP-3 inhibitors, and RNA interference-based
29 April 2026
···

Food Allergy Drugs Market 2034

DelveInsight’s Food Allergy Market Insights report includes a comprehensive understanding of current treatment practices, food allergy emerging drugs, market share of individual therapies, and current and forecasted food allergy market size from 2020 to 2034, segmented into 7MM [the United States, the EU-4 (Italy,
28 April 2026
Lassa Fever Pipeline
·

Lassa Fever Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, Treatment Market, MOA, ROA, and Companies by DelveInsight

DelveInsight’s “Lassa Fever – Pipeline Insight, 2026” provides a detailed view of the evolving pipeline, emphasizing efforts to deliver first-in-class therapies and vaccines to endemic populations. The report highlights global R&D activity, platform technologies, and regulatory incentives accelerating development timelines.Lassa Fever, an
9 April 2026
1 2 3

    Banner

    Newsletter